Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the metagenomic sequencing market right now?
The market size for metagenomic sequencing has seen a rapid upsurge in recent years. The market is projected to expand from $2.13 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 17.5%. The notable growth during the historic period is primarily due to several factors, such as an increase in government participation, a rise in the number of research projects centered around metagenome sequencing, an increment in the application of metagenomics in genomics and diagnostic research studies, the provision of funds for research, and advancements in Next Generation Sequencing (NGS) data analysis tools.
How fast Is the metagenomic sequencing market expected to grow, and what’s its future value?
Over the coming years, the metagenomic sequencing market is projected to experience rapid expansion. Forecasts suggest it will reach a value of $4.71 billion by 2029, with a compound annual growth rate (CAGR) of 17.1%. The anticipated growth within this timeframe can be linked to factors such as reduced computational costs, increases in the search for unique biomolecules, the rising use of high-throughput sequencing technologies, growing demand for individualized medicine and disease diagnostics, and the escalation in infectious disease prevalence. Several trends propelling this projected growth encompass innovative advancements, the application of advanced genomic technologies in metagenomics, enhanced research and development funding, further progression in sequencing technology, and the utilization of big data in NGS data analysis.
Get your metagenomic sequencing market report here!
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report
What are the leading drivers of growth in the metagenomic sequencing market?
The metagenomic sequencing market’s expansion is anticipated to be fueled by a rise in the occurrence of infectious diseases. Infectious diseases are illnesses triggered by pathogenic microbes such as bacteria, viruses, fungus, or parasites, which can be transmitted either directly or indirectly between individuals. With an increase in conditions that compromise the immune system, including HIV/AIDS, cancer treatments, and autoimmune disorders, people become more vulnerable to these infections. Metagenomic sequencing serves as a robust and versatile tool for investigating infectious diseases, offering crucial knowledge about the variety of pathogens, methods of transmission, resistance to antimicrobial agents, and monitoring of outbreaks. For example, in January 2023, the Government of Canada, a federal authority based in Canada, reported that 135 rabies samples were submitted in October 2022, and 159 were submitted in November 2022. Further, in March 2023, the US’s Centers for Disease Control and Prevention reported a 5.9% increase in tuberculosis (TB) cases, with numbers rising from 7,874 in 2021 to 8,331 in 2022. Consequently, the rising frequency of infectious diseases is fueling the growth of the metagenomic sequencing market.
What are the key segments defining the metagenomic sequencing market?
The metagenomic sequencing market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications
Subsegments:
1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)
2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments
3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing
4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp
Who are the key players steering the development of the metagenomic sequencing market?
Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH
What emerging trends are influencing the growth of the metagenomic sequencing market?
Leading businesses in the metagenomic sequencing market are strategically innovating their sequencing services with the aim of enhancing sequencing precision, throughput, and cost efficiency. These innovative services are essentially a culmination of advanced genomic technologies that facilitate the sequencing of larger DNA segments, yielding a more extensive understanding of genetic structures as opposed to conventional short-read techniques. For instance, Clinical Microbiomics A/S, a biotechnology firm based in Denmark, introduced a sophisticated range of long-read sequencing services in April 2024. These include 16S, ITS, 18S rRNA, tailor-made gene sequencing, along with comprehensive genomics and metagenomics. This variety of services offers unmatched resolution and quality in microbial analysis, paving the way for comprehensive insights into microbial communities and enabling the production of superior metagenome-assembled genomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16117
Which regions are most influential in expanding the metagenomic sequencing market?
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Next Generation Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Single-Cell Genome Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Clinical Oncology Next Generation Sequencing Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
